LKT Labs

Biochemicals for Life Science Research

BYL719

BYL719

Product ID B9700
Cas No. 1217486-61-7
Purity ≥99%, ≥99%ee
Product Unit SizeCostQuantityStock
1 mg $49.70 In stock
5 mg $93.80 In stock
25 mg $159.90 In stock
100 mg $518.20 In stock
Bulk Quote

Quicklinks

Description

BYL-719 is an ATP-competitive oral PI3K inhibitor selective for the p110α isoform that is activated by a mutant PIK3CA gene in HER2+ breast cancers and gastric cancers. BYL-719 exhibits anticancer chemotherapeutic activity and inhibits proliferation in a variety of cell lines. IGF1 and neuregulin 1 activate mTOR, a downstream target of PI3K that mediates resistance to BYL-719 in some in vitro cancer models. This compound also decreases invasion and epithelial-to-mesenchymal transition (EMT) in cellular and animal models of squamous cell lung cancer.

Product Info

Cas No.

1217486-61-7
Purity

≥99%, ≥99%ee
Formula

C19H22F3N5O2S
Formula Wt.

441.47
IUPAC Name

(2S)-1-N-[4-methyl-5-[2-(1,1, 1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1, 3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide
Synonym

Alpelisib, NVP-BYL719, BYL-719
Solubility

DMSO 88 mg/mL (199.33 mM) Ethanol 2 mg/mL (4.53 mM) Water Insoluble
Appearance

White Crystal Powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

B9700 MSDS PDF
Info Sheet

B9700 Info Sheet PDF

References

Bonelli MA, Cavazzoni A, Saccani F, et al. Inhibition of PI3K pathway reduces invasiveness and epithelial-to-mesenchymal transition in squamous lung cancer cell lines harboring PIK3CA gene alterations. Mol Cancer Ther. 2015 May 26. [Epub ahead of print]. PMID: 26013318.

Elkabets M, Vora S, Juric D, et al. mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA-Mutant Breast Cancer. Sci Transl Med. 2013 Jul 31;5(196):196ra99. PMID: 23903756.

Abstract: Juric. BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study. American Association for Cancer Research. 2012.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • O9256

    16-Oxocafestol

    Synthetic cafestol derivative.
    ≥97%
  • T1953

    Tenovin-3

    Potential p53 activator or SIRT2 inhibitor.
    ≥98%
  • L0209

    Lactoferrin, cow

    Endogenous glycoprotein; lactoferrin agonist.
    ≥92%
  • R0110

    Ractopamine Hydrochloride

    β1/2-adrenergic agonist.
    ≥97%
  • M4454

    MLN-4924

    Nedd8-activating enzyme inhibitor.
    ≥99%
  • T7860

    TTP 22

    Casein kinase 2 inhibitor.
    ≥98%
  • G7444

    GSK-1070916

    AurKB/C inhibitor.
    ≥98%
  • F4680

    Flutamide

    Non-steroid; AR antagonist.
    ≥98%
  • S0170

    Sarafloxacin Hydrochloride

    Fluoroquinolone; topoisomerase IV and bacterial DN...
    ≥91%
  • S8013

    [Tyr8]-Substance P

    Endogenous tachykinin peptide, involved in inflamm...
    ≥95%
  • B1876

    Betamethasone

    Steroid; glucocorticoid agonist.
    ≥98%
  • T3036

    Thienylhexyl Isothiocyanate

    Thienylbutyl ITC analog.
    ≥97%
  • L8010

    D-Luciferin Potassium

    Heterocyclic light-emitting compound, natural liga...
    ≥98%
  • Q4370

    QKRPSQRSKYL

    Peptide, PKC substrate.
    ≥95%
  • V0273

    Vasoactive Intestinal Peptide

    Endogenous peptide hormone, involved in enteric mo...
    ≥95%
  • C1176

    CCT-128930

    Pyrrolopyrimidine; Akt inhibitor.
    ≥98%
  • AS112

    Grape Skin Standards Kit

    Grape Skin Standards Kit Contents: -Column: Cosmos...
  • F5968

    Foretinib

    ROS1, MET, Ron, Axl, TIE-2, VEGFR2 inhibitor.
    ≥98%
  • E6782

    S-Equol

    Isoflavone, phytoestrogen found in soy; ER agonist...
    ≥99%
  • C0379

    Catch-Relaxing Peptide

    Peptide, found in molluscs; BK/SK K+ channel modul...
    ≥95%